Pharma should be thinking more about the microbiome, as growing evidence reveals its significant impact on drug efficacy, a personalized nutrition expert revealed during NutraIngredients’ 2024 Probiota event.
A Thai researcher has invented a personalised probiotics dispenser machine that supplies consumers with probiotics strains that they lack in their gut, using bioinformatics and artificial intelligence (AI).
A Paris-based personalised supplements service is working to become a ‘one stop shop’ for high quality tailored supplements delivered to customers' doors.
Microbiome therapeutics firm MyBiotics Pharma have received €2m ($2.3m) in funding by the European Union (EU) to develop technology capable of delivering personalised probiotics to tackle gut-related diseases.
